Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm(1) and launches new comprehensive chronic kidney disease (CKD) algorithm panel
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Unternehmen
Swiss Central City Real Estate Fund, c/o Nova Property Fund Management AG --- Swiss Central City Real Estate Fund verbessert Nachhaltigkeits-Performance und erreicht erneut 4 Sterne im GRESB-Rating 2025
» Report
Glarner Kantonalbank - Spende für den Nachwuchs des Glarner Schwingerverbands: Glarner Kantonalbank gibt Erlös aus T-Shirt-Verkauf weiter
» Report
Invitation to Roche’s Virtual Ophthalmology Investor Event
» Report
Übernahmekommission: u-blox Holding AG
» Report
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
» Report
BfS: Film- und Kinostatistik: Neue Zahlen zum Kinojahr 2025
» Report
BfS: Touristische Beherbergung von Januar bis August 2025
» Report
Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
» Santhera
Clariant rejects allegations from BP Europe and ExxonMobil against four companies related to the 2020 competition law infringement
» Report
ALSO realigns Group Management Board - Faster decision-making to increase effectiveness
» Report
ALSO richtet Konzernleitung neu aus - Schnellere Entscheidungswege zur Erhöhung der Schlagkraft
» Report
Partners Group and CVC agree partnership to drive next phase of growth at International Schools Partnership, a leading global K-12 school platform
» Report
Change in the Roche Board of Directors
» Report
Roche: FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
» Report
Logitech - 8-K (Current report filing) SEC Filing
» Report
Kudelski Group: NAGRAVISION's OpenTV® ENTera Wins Multiple Industry Awards
» Report
Investis strengthens its financial position through partial divestment of its stake in PHM
» Report
Investis renforce sa situation financière grâce à la cession partielle de sa participation dans PHM
» Report
